Marjo Nylund
MSc
Turku PET Centre marjo.k.nylund@utu.fi +358 29 450 4743 +358 50 472 8266 Itäinen Pitkäkatu 4 Turku |
1 of 2
- Integrating TSPO-PET imaging with metabolomics for enhanced prognostic accuracy in multiple sclerosis (2025)
- BMJ neurology open
- A Novel Comprehensive Epigenomic Liquid Biopsy Assay Reveals Disease Biology in Multiple Sclerosis Patients from 1 mL of Plasma (2024)
- Multiple Sclerosis
- P2X 7-receptor binding in new-onset and secondary progressive MS – a [11C]SMW139 PET study (2024)
- EJNMMI Research
- Sex-driven variability in TSPO-expressing microglia in MS patients and healthy individuals (2024)
- Frontiers in Neurology
- Synaptic density in multiple sclerosis: An in vivo study using [11C]UCB-J-PET imaging (2024)
- Multiple Sclerosis
- TSPO-PET-measurable microglial activity remains unaltered in cladribine-treated RRMS patients (2024)
- Multiple Sclerosis
- Early prognosticators of later TSPO-PET-measurable microglial activation in multiple sclerosis (2023)
- Multiple Sclerosis and Related Disorders
- Longitudinal stability of progression-related microglial activity during teriflunomide treatment in patients with multiple sclerosis (2023)
- European Journal of Neurology
- PET-measurable innate immune cell activation reduction in chronic active lesions in PPMS brain after rituximab treatment: a case report (2023)
- Journal of Neurology
- TSPO-Detectable Chronic Active Lesions Predict Disease Progression in Multiple Sclerosis (2023)
- Neurology, Neuroimmunology and Neuroinflammation
- Innate Immune Cell-Related Pathology in the Thalamus Signals a Risk for Disability Progression in Multiple Sclerosis (2022)
- Neurology, Neuroimmunology and Neuroinflammation
- Phenotyping of multiple sclerosis lesions according to innate immune cell activation using TSPO-PET (2022)
- Brain Communications
- Brain TSPO-PET predicts later disease progression independent of relapses in multiple sclerosis (2020)
- Brain
- Drug reaction with eosinophilia and systemic symptoms after ocrelizumab therapy (2020)
- Multiple Sclerosis and Related Disorders
- Frequency and etiology of acute transverse myelitis in Southern Finland (2020)
- Multiple Sclerosis and Related Disorders
- Insights into disseminated MS brain pathology with multimodal diffusion tensor and PET imaging (2020)
- Neurology, Neuroimmunology and Neuroinflammation
- Rituximab in the treatment of multiple sclerosis in the Hospital District of Southwest Finland (2020)
- Multiple Sclerosis and Related Disorders
- Serum glial fibrillary acidic protein correlates with multiple sclerosis disease severity (2020)
- Multiple Sclerosis
- Natalizumab treatment reduces microglial activation in the white matter of the MS brain (2019)
- Neurology, Neuroimmunology and Neuroinflammation
- Rituksimabi MS-taudin hoidossa (2019)
- Duodecim
UTU Research Portal